[Skip to Content]
[Skip to Content Landing]
Views 66
Citations 0
Comment & Response
December 15, 2016

Lymphoma and Pregnancy

Author Affiliations
  • 1Oncology Research Unit, Oncology Hospital, National Medical Center, Instituto Mexicano del Seguro Social, México, Mexico
  • 2Hematology Department, Oncology Hospital, National Medical Center, Instituto Mexicano del Seguro Social, México, Mexico
JAMA Oncol. Published online December 15, 2016. doi:10.1001/jamaoncol.2016.5290

To the Editor We read carefully the recent article by Pinnix et al1 about the treatment of patients with malignant lymphoma and Hodgkin lymphoma, which showed that standard treatment (cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate, and prednisone [CHOP] or CHOP-like) administered to mothers with malignant lymphoma is well tolerated by the mother, without excessive toxicity, and with an excellent outcome (overall survival) compared with nonpregnant women who received the same treatment, as previously reported.24

First Page Preview View Large
First page PDF preview
First page PDF preview
×